Amphastar Pharmaceuticals, Inc.

AMPH · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.0B · 1,976 employees
178
SEC Filings
$28.02
Close 2026-11-04
1,976
Employees

Business Summary

Amphastar Pharmaceuticals is a biopharmaceutical company focused on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as active pharmaceutical ingredients. Key products include BAQSIMI glucagon nasal powder, Primatene MIST, glucagon, epinephrine, and lidocaine. For 2025, the company recorded net revenues of $719.9 million and net income of $98.1 million.

Latest Stock Quote

AMPH 2026-11-04 $28.02 O:$27.37 H:$28.565 L:$27.09 Vol:0.6M VWAP:$28.0486
origin leaf: null

Next Earnings

expected 2027-02-04

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001297184-26-000009EDGAR102K words
2025-03-032024-12-310001297184-25-000008EDGAR101K words
2024-02-292023-12-310001297184-24-000009EDGAR107K words
2023-03-012022-12-310001297184-23-000019EDGAR99K words
2022-03-112021-12-310001297184-22-000007EDGAR104K words
2021-03-152020-12-310001297184-21-000008EDGAR103K words
2020-03-162019-12-310001297184-20-000007EDGAR100K words
2019-03-152018-12-310001297184-19-000013EDGAR102K words
2018-03-142017-12-310001297184-18-000011EDGAR100K words
2017-03-152016-12-310001297184-17-000007EDGAR101K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-052026-09-300001297184-26-000053EDGAR32K words
2026-08-062026-06-300001297184-26-000047EDGAR31K words
2025-11-062025-09-300001297184-25-000064EDGAR33K words
2025-08-072025-06-300001297184-25-000050EDGAR32K words
2025-05-082025-03-310001297184-25-000029EDGAR25K words
2024-11-072024-09-300001297184-24-000058EDGAR33K words
2024-08-092024-06-300001297184-24-000048EDGAR32K words
2024-05-102024-03-310001297184-24-000037EDGAR27K words
2023-11-082023-09-300001297184-23-000082EDGAR40K words
2023-08-092023-06-300001297184-23-000066EDGAR37K words
2023-05-092023-03-310001297184-23-000049EDGAR30K words
2022-11-082022-09-300001297184-22-000056EDGAR36K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-050001297184-26-000051EDGAR6K words
2026-08-060001297184-26-000045EDGAR6K words
2026-07-130001104659-26-082772EDGAR1K words
2026-03-160001104659-26-027814EDGAR1K words
2026-03-060001297184-26-000015EDGAR14K words
2026-03-060001297184-26-000013EDGAR6K words
2026-02-260001297184-26-000007EDGAR7K words
2026-01-120001297184-26-000002EDGAR1K words
2025-11-060001297184-25-000062EDGAR6K words
2025-10-240001297184-25-000058EDGAR1K words

178 total filings indexed. 146 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

u.s.-injectable-drug-market-(over-$480-billion-in-2025) u.s.-inhalation-drug-market-(approximately-$27-billion-in-2025) active-pharmaceutical-ingredient-(api)-market intranasal-drug-delivery-market international-pharmaceutical-markets-(26-countries-for-baqsimi) current-good-manufacturing-practice-(cgmp) hfa-(hydrofluoroalkane)-metered-dose-inhaler-formulations bioequivalence-studies-for-fda-anda-approval biologics-license-applications-(bla) abbreviated-new-drug-applications-(anda)

Company Identity

CIK0001297184
TickerAMPH
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
Websitehttps://www.amphastar.com
Listed2014-06-25

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 82d25bb4103c66a6db4ff97ad5679a293f9c03ea1306f6956c9727fecbb5deca
parent: 250fe269673a04cd4723fc67c0d7d96f3c843f592844ba951def7e488c1412f9
content hash: 24a3fc835983b861e4e4cbbf56ea92fea995f037a6481a51e86243818e6dc8a1
signed: 2026-11-16T19:00:28.684Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up AMPH using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on AMPH, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/AMPH (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.